Good evening :)
$
₹
SIGA Technologies Inc

SIGA Technologies Inc

SIGA

NASDAQ
Asset Logo

SIGA Technologies Inc

SIGA

NASDAQ
$2.975.55% (-0.17)
$
₹
$2.975.55% (-0.17)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Drug Manufacturers - Specialty & Generic

Micro Cap

With a market cap of $223.5M the stock is ranked 4172

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

1.28
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-0.04
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

3.36
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-5.19%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

0%

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on consolidated analysts reports

?

Buy, Sell and Hold recommendations are not available

Price Upside

+456.51%

Earnings Growth

-84.36%

Rev. Growth

-36.72%

See Detailed Forecast

Company Profile

Company Profile

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Eli Lilly and Company
LLY
Eli Lilly and Company
P/E Ratio
45.78
45.78
1Y Return
56.59%
56.59%
Buy Reco %
83.87
83.87
Johnson & Johnson
JNJ
Johnson & Johnson
P/E Ratio
40.39
40.39
1Y Return
48.81%
48.81%
Buy Reco %
69.56
69.56
Merck & Company Inc
MRK
Merck & Company Inc
P/E Ratio
149.14
149.14
1Y Return
79.29%
79.29%
Buy Reco %
67.85
67.85
Novartis AG ADR
NVS
Novartis AG ADR
P/E Ratio
30.39
30.39
1Y Return
31.97%
31.97%
Buy Reco %
41.66
41.66
AstraZeneca PLC
AZN
AstraZeneca PLC
P/E Ratio
26.00
26.00
1Y Return
11.26%
11.26%
Buy Reco %
75.00
75.00
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 456.51% growth, versus a trailing 3-year CAGR of -9.51%.

2026
Current$3.15Baseline
Analyst Target - 1 year
Target$17.53+456.51%

All values in $

202220232024202520262027$6.95$11.06$15.17Target+456.51%
2026
Current$3.15Baseline
Analyst Target - 1 year
Target$17.53+456.51%

All values in $

Revenue Forecast

Revenue Forecast

Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies -36.72% growth, versus a trailing 3-year CAGR of -5.13%.

2025
Current$94.6Baseline
Forecast for Dec 2026
High$59.86-36.72%
Average$59.86-36.72%
Low$59.86-36.72%

All values in $ Million

202120222023202420252026133.67110.77139.91138.7194.6Low-36.72%Average-36.72%High-36.72%
2025
Current$94.6Baseline
Forecast for Dec 2026
High$59.86-36.72%
Average$59.86-36.72%
Low$59.86-36.72%

All values in $ Million

Earnings Per Share Forecast

Earnings Per Share Forecast

Lower earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies -84.36% growth, versus a trailing 3-year CAGR of -11.43%.

2025
Current$0.32Baseline
Forecast for Dec 2026
High$0.05-84.36%
Average$0.05-84.36%
Low$0.05-84.36%

All values in $

2021202220232024202520260.920.460.960.830.32Low-84.36%Average-84.36%High-84.36%
2025
Current$0.32Baseline
Forecast for Dec 2026
High$0.05-84.36%
Average$0.05-84.36%
Low$0.05-84.36%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

2.6
-6.3
3.8
-5.4
6.2
-3.4
41
12.4
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue25.4221.811081.467.0481.122.623.86.2441
Net Income10.271.831.3445.76-0.4035.48-6.36-5.4-3.4512.46
Net Profit Margin40.41%8.40%13.42%56.16%-5.79%43.74%-242.97%-142.10%-55.33%30.39%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareDrug Manufacturers - Specialty & Generic

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
SIGA Technologies Inc -1.283.36
Eli Lilly and Company45.7831.351.35
Johnson & Johnson40.397.983.04
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare SIGA with any stock or ETF
Compare SIGA with any stock or ETF
Comparing from
SIGA
LLY
JNJ
Loading...

Frequently asked questions

  1. SIGA Technologies Inc (SIGA) share price today is $2.97 as of November 5, 2026 at 11:14 PM IST. The stock touched a day high of $3.13 and a day low of $2.97.

  2. SIGA Technologies Inc stock trades on NASDAQ under the ticker symbol SIGA.

  3. SIGA Technologies Inc's market capitalization is $223.45M as of November 5, 2026 at 11:14 PM IST.

  4. SIGA Technologies Inc's price-to-earnings (P/E) ratio is N/A as of November 5, 2026.

  5. SIGA Technologies Inc's price-to-book (P/B) ratio is 1.28 as of November 5, 2026.

  6. No, SIGA Technologies Inc does not currently pay a dividend.

  7. Yes, You can buy SIGA Technologies Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy SIGA Technologies Inc shares in three steps: 1. Search SIGA Technologies Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since SIGA Technologies Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in SIGA Technologies Inc (SIGA) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 3.3613 shares at the current price of $2.97.

Loading...